Multivariate analysis of baseline characteristics associated with time-to-progression events, restricted to those patients who became PET-NEG at EOT
| Characteristic . | HR . | 95% CI . | P . |
|---|---|---|---|
| Age >60 years | 0.9 | 0.5-1.4 | .5 |
| ECOG PS >1 | 0.9 | 0.5-1.5 | .6 |
| Extranodal sites >1 | 1.0 | 0.6-1.6 | .9 |
| Ann Arbor stage III/IV | 1.5 | 0.6-3.8 | .3 |
| Elevated LDH | 1.3 | 0.8-2.2 | .3 |
| Hb <110 g/L | 1.3 | 0.7-2.2 | .4 |
| B symptoms | 2.0 | 1.2-3.2 | .007 |
| Marrow involvement | 2.9 | 1.7-5.0 | <.0001 |
| Characteristic . | HR . | 95% CI . | P . |
|---|---|---|---|
| Age >60 years | 0.9 | 0.5-1.4 | .5 |
| ECOG PS >1 | 0.9 | 0.5-1.5 | .6 |
| Extranodal sites >1 | 1.0 | 0.6-1.6 | .9 |
| Ann Arbor stage III/IV | 1.5 | 0.6-3.8 | .3 |
| Elevated LDH | 1.3 | 0.8-2.2 | .3 |
| Hb <110 g/L | 1.3 | 0.7-2.2 | .4 |
| B symptoms | 2.0 | 1.2-3.2 | .007 |
| Marrow involvement | 2.9 | 1.7-5.0 | <.0001 |
Bold P values indicates statistical significance.
IPI, International Performance Index; LDH, lactate dehydrogenase.